Related Experiment Video
Updated: Jun 26, 2026
06:23
Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Heme oxygenase and renal disease
1Division of Nephrology, THT 647, University of Alabama at Birmingham, 1900 University Boulevard, Birmingham, AL 35294, USA.
Current Hypertension Reports
|January 17, 2009
Summary
Heme oxygenase-1 (HO-1) plays a crucial role in kidney diseases by regulating heme breakdown. Its antioxidant and anti-inflammatory properties offer protective benefits in various kidney injury models.
Area of Science:
- Biochemistry
- Cellular Biology
- Nephrology
Background:
- Heme homeostasis is critical for cellular function and is regulated by the heme oxygenase (HO) enzyme system.
- HO catalyzes heme degradation, producing iron, carbon monoxide, and biliverdin, which possess significant antioxidant, anti-inflammatory, and cytoprotective effects.
- Two HO isoforms exist: inducible HO-1 and constitutive HO-2. HO-1 is upregulated by injurious stimuli.
Purpose of the Study:
- To review the role and significance of heme oxygenase-1 (HO-1) in the context of kidney diseases.
- To highlight the protective mechanisms conferred by HO-1 in various renal injury models.
Main Methods:
- This review synthesizes findings from recent scientific literature.
- Focuses on studies investigating the biological effects of HO-1 in renal pathophysiology.
Main Results:
- HO-1 induction is a beneficial response to cellular injury, offering protection against oxidative stress and inflammation.
- HO-1 has demonstrated therapeutic potential in preclinical models of sepsis, hypertension, atherosclerosis, and acute lung and kidney injury.
- The cytoprotective, antioxidant, and anti-inflammatory properties of HO-1 are key to its protective role in the kidney.
Conclusions:
- Heme oxygenase-1 (HO-1) is a critical mediator of cellular protection in the kidney.
- Targeting HO-1 activation represents a promising therapeutic strategy for managing diverse kidney diseases.
Related Concept Videos
01:29Renal Regulation of Acid-Base Balance
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
01:28Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: